Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

Federal Trade Commission
Dow
Mallinckrodt
McKesson
QuintilesIMS
Chinese Patent Office
Express Scripts
Accenture
Fish and Richardson

Generated: December 15, 2018

DrugPatentWatch Database Preview

CLINICAL TRIALS PROFILE FOR IMIPENEM AND CILASTATIN

« Back to Dashboard

Clinical Trials for Imipenem And Cilastatin

Trial ID Title Status Sponsor Phase Summary
NCT00080496 Study Evaluating Tigecycline Versus Imipenem/Cilastatin in Hospital-Acquired Pneumonia Completed Wyeth is now a wholly owned subsidiary of Pfizer Phase 3 To compare the efficacy and safety of the tigecycline regimen with that of the imipenem/cilastatin regimen in subjects with nosocomial pneumonia.
NCT00081744 Study Comparing Tigecycline to Imipenem/Cilastatin in Complicated Intra-Abdominal Infections in Hospitalized Subjects Completed Wyeth is now a wholly owned subsidiary of Pfizer Phase 3 Purpose: To provide a mechanism for the emergency use of tigecycline in the appropriate clinical situations.
NCT00136201 Study Comparing Tigecycline and Imipenem/Cilastatin in Chinese Subjects With Complicated Intra-Abdominal Infections Completed Wyeth is now a wholly owned subsidiary of Pfizer Phase 3 The primary objective of this study is to compare the safety and efficacy of an experimental antibiotic to a marketed antibiotic in the treatment of Chinese subjects with complicated intra-abdominal infections.
Trial ID Title Status Sponsor Phase Summary

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

Clinical Trial Conditions for Imipenem And Cilastatin

Condition Name

Condition Name for Imipenem And Cilastatin
Intervention Trials
Urinary Tract Infections 3
Abdominal Abscess 2
Bacterial Pneumonia 2
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Condition MeSH

Condition MeSH for Imipenem And Cilastatin
Intervention Trials
Infection 16
Communicable Diseases 14
Pneumonia 7
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Locations for Imipenem And Cilastatin

Trials by Country

Trials by Country for Imipenem And Cilastatin
Location Trials
United States 49
China 29
Brazil 6
Canada 6
France 6
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Trials by US State

Trials by US State for Imipenem And Cilastatin
Location Trials
Ohio 4
California 4
Illinois 3
North Carolina 2
Maryland 2
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Progress for Imipenem And Cilastatin

Clinical Trial Phase

Clinical Trial Phase for Imipenem And Cilastatin
Clinical Trial Phase Trials
Phase 4 5
Phase 3 11
Phase 2 7
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Status

Clinical Trial Status for Imipenem And Cilastatin
Clinical Trial Phase Trials
Completed 12
Recruiting 8
Terminated 3
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Sponsors for Imipenem And Cilastatin

Sponsor Name

Sponsor Name for Imipenem And Cilastatin
Sponsor Trials
Merck Sharp & Dohme Corp. 10
Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 3
Wyeth is now a wholly owned subsidiary of Pfizer 3
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Sponsor Type

Sponsor Type for Imipenem And Cilastatin
Sponsor Trials
Industry 25
Other 10
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Cantor Fitzgerald
Fuji
Express Scripts
Deloitte
Citi
Colorcon
Queensland Health
Cerilliant
Boehringer Ingelheim

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.